Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2022-12-19 00:00:00 ET · period of report 2022-01-31 · accession 0001493152-22-035926 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-19 | 2022-01-31+ | INDP | Litchev Boyan Vesselinov | Chief Medical Off | P - Purchase | $2.19 | +1,150 | 150 | New | +$2,520 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-22 | P | A | 500 | $1.83 | 650 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-01 | P | A | 500 | $1.87 | 1,150 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-31 | P | A | 100 | $4.65 | 100 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-02 | P | A | 50 | $4.09 | 150 | D | — | — |